Psychotropic drug influences on brain acetylcholine utilization.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D006426:Hemicholinium 3 / Q000037:antagonists & inhibitors; D007099:Imipramine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008728:Methotrimeprazine / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010622:Phencyclidine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012601:Scopolamine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D006426:Hemicholinium 3; D002707:Chlordiazepoxide; D009020:Morphine; D008238:Lysergic Acid Diethylamide; D008728:Methotrimeprazine; D012601:Scopolamine; D010424:Pentobarbital; D010622:Phencyclidine; D000109:Acetylcholine; D007099:Imipramine; D003913:Dextroamphetamine; D002746:Chlorpromazine